- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05924035
HBOT and Exercise Recovery
Effect of Hyperbaric Oxygen Treatment (HBOT) on Recovery From Exercise
Study Overview
Detailed Description
Initial visit to discuss the study and obtain consent. At this visit, baseline subject demographics (height, weight, body composition) and a medical history will be taken to confirm that there are no medical contraindications to either exercise or HBOT. This visit will likely take 30-45 minutes.
There will be 15 subsequent visits. Each of these visits will be conducted concurrent with their standard off-season workouts. An additional 15 minutes per workout session may be required for the collection of study-related, non-standard of care, outcome measures.
During the second week of the study, the experimental group will have four daily 90 minute sessions of HBOT. Travel time from the site of their workouts (West Haven CT) to the HBOT facility (Bridgeport Hospital) is approximately 20 minutes.
Immediately following exercise, each experimental subject will be fitted with the surface muscle oxygenation monitor on their vastus lateralis. This monitor (Moxy, Fortiori Design LLC) utilizes near-infrared spectroscopy. The monitor will be applied to the distal third of the vastus lateralis muscle (12cm above the knee joint) as identified and marked by the PI (an orthopaedic surgeon). This will provide continuous muscle oxygenation report following exercise, including during and immediately after the HBOT treatment.
Both the experimental and control groups will have blood lactate measurements taken within 15 minutes before the start of their daily exercise, as well as within 5 minutes of the completion of exercise, utilizing The Edge blood lactate monitoring system (Apexbio, Taiwan). Once per week the performance of The Edge monitor will be validated utilizing The Edge Lactate Control Solution.
The Edge monitor measures blood lactate from a drop of blood from a finger tip applied to a sterile lancet. The result is reported in approximately 45 seconds.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Yale University varsity student-athletes
- Cleared for unrestricted participation in varsity athletics training at the time of data collection
- No implantable electronic medical device (ie. Deep brain stimulator or insulin pump) or with other contraindication to HBOT
- Those who consent to participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
Control Group will participate in standardized, prescribed exercise 4 days per week and perform countermovement jumps on a force plate both before and after daily workouts (standard of care summer athletic training)
|
|
|
Experimental: HBOT Treatment
HBOT Treatment Group will receive HBOT Treatment in addition to standardized, prescribed exercise 4 days per week and perform countermovement jumps on a force plate both before and after daily workouts (standard of care summer athletic training)
|
HBOT treatment on a multiplace chamber (OXYHeal Hyperbaric Oxygen Chamber), 100% oxygen at 2.0 atmospheres for 90 minutes - on 4 consecutive days within 3 hours of completion of exercise training (as soon as practically possible).
This will occur during week 2 of data collection.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relative Peak Propulsive Power
Time Frame: within 3 hours of exercise completion during week 2
|
Relative Peak Propulsive Power will be assessed as the peak instantaneous mechanical power applied to the system center of mass during the population phase relative to the system mass from a countermovement jump using the Hawkin Dynamic force plates.
|
within 3 hours of exercise completion during week 2
|
|
modified Relative Strength Index (mRSI)
Time Frame: within 3 hours of exercise completion during week 2
|
mRSI assessed as jump height calculated using the vertical velocity of the system center of mass at the instant of take-off divided by the total time taken from the initiation of movement to the instant of take-off using the Hawkin Dynamic force plates.
|
within 3 hours of exercise completion during week 2
|
|
Average Landing Force
Time Frame: within 3 hours of exercise completion during week 2
|
Average Landing Force assessed as the average vertical ground reaction force applied to the system center of mass during the landing phase using the Hawkin Dynamic force plates.
|
within 3 hours of exercise completion during week 2
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Muscle oxygenation
Time Frame: baseline and week 2
|
Muscle oxygenation will be measured during and post exercise, with and without HBOT using a surface muscle oxygenation monitor on their vastus lateralis.
|
baseline and week 2
|
|
Change in Blood lactate
Time Frame: baseline and week 2
|
Blood lactate will be measured pre- and post-exercises, and post-HBOT using The Edge blood lactate monitoring system.
The Edge monitor measures blood lactate from a drop of blood from a finger tip applied to a sterile lancet.
The result is reported in approximately 45 seconds.
|
baseline and week 2
|
|
Rate of Perceived Exertion (RPE) scale
Time Frame: daily up to 3 weeks
|
The scale allows participants to subjectively rate their perceived level of exertion during exercise.
It is scored from 0 (Nothing at all) to 11 (very, very hard) and reported using self-report.
A higher score indicates more perceived exertion.
|
daily up to 3 weeks
|
|
Rate of Perceived Recovery (RPR) scale
Time Frame: daily up to 3 weeks
|
The scale allows participants to subjectively rate their perceived level of recovery from last exercise session.
It is scored from 0 (very poor recovery/extremely tired) to 11 (very good recovery/extremely well-disposed) and reported using self-report.
A higher score indicates more perceived recovery.
|
daily up to 3 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Elizabeth Gardner, MD, Yale University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2000035148
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise Recovery
-
Uludag UniversityThe Scientific and Technological Research Council of TurkeyCompletedEndurance Exercise | Muscle Fatigue | Exercise Performance Recovery | Recovery MethodsTurkey (Türkiye)
-
Istanbul Sabahattin Zaim UniversityT.C. Dumlupınar ÜniversitesiCompletedExercise Ergogenics | Recovery Methods | Carnitine Ingestion | Exercise Fatigue | Exercise and RecoveryTurkey (Türkiye)
-
Tel Aviv UniversityRecruiting
-
University of BathRecruitingExercise RecoveryUnited Kingdom
-
University of Nove de JulhoCompleted
-
University of Nove de JulhoRecruiting
-
Maastricht University Medical CenterCompletedExercise RecoveryNetherlands
-
Montana State UniversityMontana State Agricultural Experiment StationRecruitingInflammation | Recovery | Oxidative Stress | Resistance Exercise | Exercise Performance RecoveryUnited States
-
Kemin Foods LCCompletedExercise Performance RecoveryUnited States
-
University Ramon LlullCompletedRecovery | Exercise Training | StrengthSpain
Clinical Trials on HBOT
-
Assaf Harofeh MCUnknown
-
University Hospital OstravaNot yet recruitingChronic Pain | Complex Regional Pain SyndromeCzechia
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Recruiting
-
Assaf-Harofeh Medical CenterUnknownIntracranial Meningioma | Neurologic DeficitsIsrael
-
Abington Memorial HospitalPhiladelphia College of Osteopathic MedicineCompletedStroke | Ischemic Stroke | Chronic Stroke | Motor DysfunctionUnited States
-
RWTH Aachen UniversityCompletedWound Healing | MicrocirculationGermany
-
Assaf-Harofeh Medical CenterWeizmann Institute of Science; Office of Naval Research (ONR)RecruitingPTSD | Peritraumatic AmnesiaIsrael
-
Mrs. Thelma Zoegas FoundationLund University; Region Skåne Sweden; Gorthons Foundation Helsingborg SwedenCompletedDiabetes | Foot Ulcer | HealingSweden
-
Legacy Health SystemDexCom, Inc.SuspendedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
Legacy Health SystemTerminated